Bullboard - Stock Discussion Forum Sonnet Biotherapeutics Holdings Inc SONN

Consumer Cyclical Biotechnology

Sonnet BioTherapeutics Holdings, Inc. is a clinical-stage, oncology-focused biotechnology company with a proprietary platform for biologic medicines of single-or bifunctional action. Its technology, namely Fully Human Albumin Binding (FHAB), utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. It designed the... see more

Add To Watchlist

NDAQ:SONN - Post Discussion

Sonnet Biotherapeutics Holdings Inc > Sonnet BioTherapeutics Issued USTPO Patent Covering Two Nove

View:

Post by whytestocks on Nov 06, 2024 10:04am

Sonnet BioTherapeutics Issued USTPO Patent Covering Two Nove

NEWS: $SONN Sonnet BioTherapeutics Issued USTPO Patent Covering Two Novel Immunotherapeutic Drug Candidates2024-11-06 08:53:45 ET DENVER, Colo., Nov 06, 2024 ( 247marketnews.com )- Sonnet BioTherapeutics (NASDAQ: SONN ) stated that the United States Patent and Trademark Office (USPTO) issued U.S. Patent# 12,134,635 entitled “Interleukin 18 (IL-18) Variants and Fusion Proteins Co...SONN - Sonnet BioTherapeutics Issued USTPO Patent Covering Two Novel Immunotherapeutic Drug Candidates